Ranbaxy plans new drug production facilities in Nigeria, Malaysia

The Nigeria facility is expected to begin production from first quarter of 2013,The Economic Times reports.

The manufacturing capacity of the Nigerian facility will range from 14 million to 100 million units of tablets and capsules per annum.

The financial details of the plants have not been disclosed.

The greenfield manufacturing facility in Nigeria is intended to supplement the company’s manufacturing capability and consolidate its position as a leader, Sawhney added.

The 2.5 billion doses per annum Malaysian facility is likely to be completed in 2014, and the products from the facility will be exported to countries like Singapore and Thailand.